Skip to main content
John Sfakianos, MD, Urology, New York, NY, Mount Sinai Beth Israel

JohnPeterSfakianosMD

Urology New York, NY

Surgical Oncology

Physician

Dr. Sfakianos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sfakianos' full profile

Already have an account?

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2012 - 2014
  • SUNY Downstate Health Sciences University
    SUNY Downstate Health Sciences UniversityResidency, Urology, 2008 - 2012
  • SUNY Downstate Health Sciences University
    SUNY Downstate Health Sciences UniversityInternship, Transitional Year, 2007 - 2008
  • Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo
    Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2007

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2012 - 2025
  • American Board of Urology Urology

Publications & Presentations

PubMed

Journal Articles

  • An Evaluation of Race, Ethnicity, Age, and Sex-Based Representation in Phase I to II Renal Cell Carcinoma Clinical Trials in the United States  
    Isuru Jayaratna, John P Sfakianos, Ketan K Badani, Urologic Oncology

Authored Content

  • An Evaluation of Race, Ethnicity, Age, and Sex-Based Representation in Phase I to II Renal Cell Carcinoma Clinical Trials in the United StatesJune 2018

Press Mentions

  • New Approaches in the Bladder-Sparing Paradigm
    New Approaches in the Bladder-Sparing ParadigmMarch 20th, 2023
  • Ask the Expert: John Sfakianos, M.D.
    Ask the Expert: John Sfakianos, M.D.June 17th, 2021
  • Novel Immune Checkpoint Axis to Understand BCG Resistance and Improve Treatment in Non-Muscle Invasive Bladder Cancer - Amir Horowitz & John Sfakianos
    Novel Immune Checkpoint Axis to Understand BCG Resistance and Improve Treatment in Non-Muscle Invasive Bladder Cancer - Amir Horowitz & John SfakianosMay 10th, 2021
  • Join now to see all

Hospital Affiliations